NASDAQ:OGI Organigram Global (OGI) Stock Price, News & Analysis $1.66 +0.01 (+0.61%) Closing price 04:00 PM EasternExtended Trading$1.68 +0.03 (+1.51%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Organigram Global Stock (NASDAQ:OGI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Organigram Global alerts:Sign Up Key Stats Today's Range$1.62▼$1.7050-Day Range$1.33▼$1.7352-Week Range$0.85▼$2.00Volume826,277 shsAverage Volume730,804 shsMarket Capitalization$222.52 millionP/E Ratio33.21Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Organigram Global Inc. (NASDAQ: OGI) is a licensed producer of cannabis and hemp products headquartered in Moncton, New Brunswick, Canada. Founded in 2013, the company operates a state-of-the-art cultivation and manufacturing facility spanning more than one million square feet. Organigram holds licenses from Health Canada to produce and sell both medical and adult-use cannabis, and it pursues Good Manufacturing Practice (GMP) certification to support international exports. The company’s product portfolio encompasses dried flower, pre-rolled joints, cannabis oils, capsules and soft gels, as well as vapourizer cartridges and extracts. Organigram distributes under a variety of brands, including Monjour, Edison and First Growth, targeting diverse consumer segments from value-focused to premium. Its cultivation methods combine indoor and greenhouse systems with automated processes designed to ensure product consistency, safety and quality. Organigram serves markets across Canada and has established partnerships to access select international markets in jurisdictions that recognize Canadian GMP certification. The company’s leadership team is led by Chief Executive Officer Greg Engel, who has guided Organigram through its public listings on the Toronto Stock Exchange and the Nasdaq in 2020. Under his management, Organigram has focused on innovation in product formats, efficiency in cultivation, and strategic brand development to navigate the evolving regulatory landscape.AI Generated. May Contain Errors. Read More Organigram Global Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks22nd Percentile Overall ScoreOGI MarketRank™: Organigram Global scored higher than 22% of companies evaluated by MarketBeat, and ranked 867th out of 947 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Organigram Global. Earnings and Valuation2.5 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Organigram Global are expected to grow in the coming year, from ($0.19) to ($0.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram Global is 33.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.38.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram Global is 33.51, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.80.Price to Book Value per Share RatioOrganigram Global has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.88% of the float of Organigram Global has been sold short.Short Interest Ratio / Days to CoverOrganigram Global has a short interest ratio ("days to cover") of 7.2.Change versus previous monthShort interest in Organigram Global has recently decreased by 3.96%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOrganigram Global does not currently pay a dividend.Dividend GrowthOrganigram Global does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.88% of the float of Organigram Global has been sold short.Short Interest Ratio / Days to CoverOrganigram Global has a short interest ratio ("days to cover") of 7.2.Change versus previous monthShort interest in Organigram Global has recently decreased by 3.96%, indicating that investor sentiment is improving. News and Social Media2.2 / 5News Sentiment0.95 News SentimentOrganigram Global has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.07 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Organigram Global this week, compared to 2 articles on an average week.Search Interest4 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Organigram Global to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Organigram Global insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.09% of the stock of Organigram Global is held by insiders.Percentage Held by InstitutionsOnly 34.63% of the stock of Organigram Global is held by institutions.Read more about Organigram Global's insider trading history. Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram Global and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OGI Stock News HeadlinesOrganigram’s Report Highlights Cannabis as Key Economic Driver in CanadaSeptember 2, 2025 | tipranks.comOrganigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada’s GDP in 2024September 2, 2025 | financialpost.comFAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."September 11 at 2:00 AM | Brownstone Research (Ad)Organigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada's GDP in 2024September 2, 2025 | businesswire.comOrganigram Global Inc. (OGI) Q3 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comOrganigram reports Q3 revenue $70.8M, consensus $68.04MAugust 13, 2025 | msn.comOrganigram Posts Wider Loss, Eyes Profitability In Near TermAugust 13, 2025 | benzinga.comOrganigram Reports Record Third Quarter Fiscal 2025 ResultsAugust 13, 2025 | financialpost.comFSee More Headlines OGI Stock Analysis - Frequently Asked Questions How have OGI shares performed this year? Organigram Global's stock was trading at $1.61 on January 1st, 2025. Since then, OGI stock has increased by 4.0% and is now trading at $1.6750. How were Organigram Global's earnings last quarter? Organigram Global Inc. (NASDAQ:OGI) issued its earnings results on Wednesday, August, 13th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.02. The business earned $50.49 million during the quarter, compared to analysts' expectations of $68.04 million. Organigram Global had a net margin of 2.86% and a negative trailing twelve-month return on equity of 8.19%. Read the conference call transcript. When did Organigram Global's stock split? Organigram Global's stock reverse split on Friday, July 7th 2023.The 1-4 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. Who are Organigram Global's major shareholders? Organigram Global's top institutional investors include Tidal Investments LLC (1.97%), AdvisorShares Investments LLC (0.60%), Baader Bank Aktiengesellschaft (0.19%) and Vontobel Holding Ltd. (0.05%). How do I buy shares of Organigram Global? Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Organigram Global own? Based on aggregate information from My MarketBeat watchlists, some other companies that Organigram Global investors own include i3 Verticals (IIIV), Ford Motor (F), Lucid Group (LCID), Trade Desk (TTD), Finance of America Companies (FOA), NVIDIA (NVDA) and Company Calendar Last Earnings8/13/2025Today9/11/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:OGI CIK1620737 Webwww.organigram.ca Phone(844) 644-4726FaxN/AEmployees860Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.05 Trailing P/E Ratio33.01 Forward P/E RatioN/A P/E GrowthN/ANet Income-$33.39 million Net Margins2.86% Pretax Margin-1.50% Return on Equity-8.19% Return on Assets-5.79% Debt Debt-to-Equity RatioN/A Current Ratio2.59 Quick Ratio1.42 Sales & Book Value Annual Sales$117.47 million Price / Sales1.88 Cash FlowN/A Price / Cash FlowN/A Book Value$2.07 per share Price / Book0.80Miscellaneous Outstanding Shares134,050,000Free Float133,930,000Market Cap$221.18 million OptionableOptionable Beta1.49 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:OGI) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.